Genpact Limited (NYSE:G) SVP Piyush Mehta Sells 12,000 Shares

Genpact Limited (NYSE:GGet Free Report) SVP Piyush Mehta sold 12,000 shares of the firm’s stock in a transaction on Friday, January 10th. The stock was sold at an average price of $42.83, for a total value of $513,960.00. Following the sale, the senior vice president now directly owns 151,182 shares of the company’s stock, valued at approximately $6,475,125.06. This represents a 7.35 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Genpact Stock Up 0.2 %

Genpact stock opened at $44.31 on Thursday. The firm’s 50 day moving average price is $44.39 and its two-hundred day moving average price is $39.54. The firm has a market cap of $7.81 billion, a PE ratio of 12.17, a P/E/G ratio of 1.54 and a beta of 1.18. Genpact Limited has a twelve month low of $30.23 and a twelve month high of $47.98. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.85 and a current ratio of 1.85.

Analysts Set New Price Targets

A number of research firms recently weighed in on G. TD Cowen increased their price target on Genpact from $40.00 to $45.00 and gave the company a “hold” rating in a research report on Friday, November 8th. Robert W. Baird raised their target price on shares of Genpact from $44.00 to $48.00 and gave the stock a “neutral” rating in a report on Friday, November 8th. Finally, Needham & Company LLC boosted their price target on shares of Genpact from $42.00 to $55.00 and gave the company a “buy” rating in a report on Monday, November 11th. Eight equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, Genpact currently has a consensus rating of “Hold” and a consensus target price of $42.33.

Get Our Latest Analysis on Genpact

Hedge Funds Weigh In On Genpact

Hedge funds have recently modified their holdings of the stock. Venturi Wealth Management LLC increased its holdings in Genpact by 74.6% in the third quarter. Venturi Wealth Management LLC now owns 2,623 shares of the business services provider’s stock worth $103,000 after buying an additional 1,121 shares during the last quarter. GAMMA Investing LLC grew its position in Genpact by 221.3% in the third quarter. GAMMA Investing LLC now owns 3,329 shares of the business services provider’s stock worth $131,000 after acquiring an additional 2,293 shares in the last quarter. Versant Capital Management Inc increased its stake in shares of Genpact by 17.0% during the 4th quarter. Versant Capital Management Inc now owns 3,178 shares of the business services provider’s stock worth $136,000 after purchasing an additional 461 shares during the last quarter. Centaurus Financial Inc. acquired a new position in shares of Genpact during the 3rd quarter worth $159,000. Finally, M&T Bank Corp bought a new position in shares of Genpact during the 3rd quarter valued at $206,000. 96.03% of the stock is owned by institutional investors and hedge funds.

Genpact Company Profile

(Get Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Featured Articles

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.